Popular weight-loss medications linked to hidden side effects, study finds
Summary
Some US states are restricting or eliminating Medicaid coverage for GLP-1 weight-loss drugs due to surging public spending, despite experts warning of long-term health costs. A new study analyzing Reddit posts found users reported unlisted side effects like fatigue and menstrual irregularities.
How coverage differs
Left outlets frame Medicaid restrictions on GLP-1 drugs as a healthcare barrier for low-income individuals, while right outlets emphasize new study findings of unlisted side effects.
- Left: States sacrifice long-term health for short-term drug cost savings Left-leaning outlets highlight that some US states are restricting or eliminating Medicaid coverage for GLP-1 weight-loss drugs, emphasizing the surging demand and the potential long-term health costs if access to these medications is limited for low-income individuals. This coverage often frames the restrictions as a barrier to healthcare.
- Right: Weight-loss drugs reveal hidden dangers, raising safety concerns Right-leaning outlets focus on a new study that found popular GLP-1 weight-loss medications are linked to previously unlisted side effects, such as fatigue and menstrual irregularities, as reported by users on Reddit. This coverage highlights potential risks associated with these widely used drugs.